SCHEMBL6740457

SCHEMBL6740457

CC(CCC(=O)O)=NOC(C)(C)C

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.41
SLC15A2 Q16348 1/20 0.41
EGLN1 Q9GZT9 5/20 0.38
ALKBH5 Q6P6C2 1/20 0.38
SUCNR1 Q9BXA5 1/20 0.38
PHF8 Q9UPP1 4/20 0.35
KDM2A Q9Y2K7 4/20 0.35
KDM5C P41229 3/20 0.35
KDM6B O15054 2/20 0.35
KDM4E B2RXH2 2/20 0.35
ACE P12821 1/20 0.32
FFAR3 O14843 1/20 0.32
HDAC3 O15379 1/20 0.32
HDAC1 Q13547 1/20 0.32
HDAC2 Q92769 1/20 0.32
HDAC8 Q9BY41 1/20 0.32
MAPK1 P28482 1/20 0.31
SLC13A3 Q8WWT9 1/20 0.31
OR51E2 Q9H255 1/20 0.31
NAALAD2 Q9Y3Q0 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15260387 0.76 LMNA (0.46) LMNASLC15A2EGLN1ALKBH5SUCNR1
SCHEMBL15260388 0.76 LMNA (0.46) LMNASLC15A2EGLN1ALKBH5SUCNR1
SCHEMBL15274237 0.76 LMNA (0.46) LMNASLC15A2EGLN1ALKBH5SUCNR1
SCHEMBL6741739 0.72 LMNA (0.42) LMNASLC15A2EGLN1ALKBH5SUCNR1
SCHEMBL29524685 0.71 LMNA (0.46) LMNASLC15A2EGLN1ALKBH5SUCNR1
SCHEMBL18807276 0.71 LMNA (0.46) LMNASLC15A2EGLN1ALKBH5SUCNR1
SCHEMBL6736880 0.71 LMNA (0.41) LMNASLC15A2EGLN1ALKBH5SUCNR1
SCHEMBL951840 0.69 FFAR3 (0.41) LMNASLC15A2EGLN1ALKBH5SUCNR1
Succinic Acid SCHEMBL27780590 0.69 LMNA (0.48) LMNASLC15A2EGLN1ALKBH5SUCNR1
SCHEMBL7595720 0.69

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6689427-B2 SUITABLE FOR THE DEPOSITION OF A MULTICOMPONENT METAL OXIDE THIN FILM CONTAINING A GROUP IV METAL SUCH AS TITANIUM; FOR EXAMPLE, TITANIUM BIS(4-(ETHOXY)IMINO-2-PENTANOATE) SAMSUNG ELECTRONICS CO., LTD. (KR) 2004-02-10 US claimed
US-20020058843-A1 Novel group IV metal precursors and a method of chemical vapor deposition using the same SAMSUNG ELECTRONICS CO., LTD. (KR) 2002-05-16 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020058843-A1 Novel group IV metal precursors and a method of chemical vapor deposition using the same TLL2, TRMT1L, TLL1 LMNA 1986/4885SLC15A2 3724/4885EGLN1 4094/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.